Figure 1: Programmable TALE-LSD1 fusion modulates chromatin at an endogenous enhancer. Figure 2: TALE-LSD1 fusions targeting 40 candidate enhancers in K562 cells. Figure 3: TALE-LSD1 fusions to ...